All News #Library
Biotech
Alkermes Pushes Narcolepsy Program to Phase 3 With Mid-Stage Data
13 Nov 2025 //
BIOSPACE
Takeda, Alkermes Reveal Narcolepsy Rivals Amid Intensifying Race
08 Sep 2025 //
FIERCE BIOTECH
Alkermes Reveal Positive Ph2 for Alixorexton in Narcolepsy Type 1
21 Jul 2025 //
PR NEWSWIRE
Alkermes plc Reports First Quarter 2025 Financial Results
01 May 2025 //
PR NEWSWIRE
Alkermes Announces Two Abstracts Accepted for Presentation at ASCO
09 May 2023 //
PRESS RELEASE

Market Place
Sourcing Support